1-5 of 5
Joanne Monreal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Assessment Of The Hematopoietic Cell Transplantation Comorbidity Index In Older Patients Receiving Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation

Chandra Keebler, MD, Joanne Monreal, AAS, Jessica K Altman, MD, Olga Frankfurt, MD, Leo I. Gordon, MD, John Galvin, MD, MPH, Jayesh Mehta, MD
Journal: Blood
Blood (2013) 122 (21): 5506.
https://doi.org/10.1182/blood.V122.21.5506.5506
Published: 2013
Journal Articles

An Institutional Experience: Correlation Between Absolute Lymphocyte Count and Survival Outcome After Reduced Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies

Kehinde U.A. Adekola, MBBS, John P. Galvin, MD, MPH, Vaibhav Sahai, MD, MSc, Oluwatoyosi A. Onwuemene, MD, Joanne Monreal, John Cashy, PhD, Jayesh Mehta, MD
Journal: Blood
Blood (2012) 120 (21): 4541.
https://doi.org/10.1182/blood.V120.21.4541.4541
Published: 2012
Journal Articles

Long-Term Remission After Hematopoietic Stem Cell Transplantation for Refractory Cutaneous T Cell Lymphoma

John P. Galvin, MD, MPH, Joanne Monreal, Joan Guitart, MD, Steve T. Rosen, MD, Timothy Kuzel, MD, Jayesh Mehta, MD
Journal: Blood
Blood (2012) 120 (21): 2028.
https://doi.org/10.1182/blood.V120.21.2028.2028
Published: 2012
Journal Articles

Busulfan, Cyclophosphamide, and Etoposide (Bu/Cy/VP-16) Is An Effective Conditioning Regimen Prior to Allogeneic or Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Non-Hodgkin’s Lymphoma

Neelima Vidula, MD, Borko Jovanovic, PhD, Jane N. Winter, MD, Jayesh Mehta, MD, Seema Singhal, MD, Stephanie F. Williams, MD, Olga Frankfurt, MD, Jessica K. Altman, MD, Joanne Monreal, AAS, Andrew M. Evens, DO, MSc, Leo I. Gordon, MD, FACP
Journal: Blood
Blood (2011) 118 (21): 4499.
https://doi.org/10.1182/blood.V118.21.4499.4499
Published: 2011
Journal Articles

Allogeneic Stem Cell Transplantation (AlloSCT) for Relapsed Hodgkin’s Lymphoma (HL) Following Autologous Stem Cell Transplantation (AuSCT): Improved Progression-Free Survival (PFS) in Patients with Graft vs Host-Disease (GvHD) Suggests a Graft vs Lymphoma (GVL) Effect.

Jessica K. Altman, MD, Leo I. Gordon, MD, Joanne Monreal, Andrew M. Evens, DO, Stephanie F. Williams, MD, Martin S. Tallman, MD, Seema Singhal, MD, Jayesh Mehta, MD, Jane N. Winter, MD
Journal: Blood
Blood (2005) 106 (11): 5455.
https://doi.org/10.1182/blood.V106.11.5455.5455
Published: 2005